Optibrium

Optibrium introduces cloud-based version of StarDrop drug discovery platform

Cloud-based version of StarDrop retains all the functionality and interactivity of desktop version with improved accessibility and lower total cost of ownership for customers Optibrium recently received ISO 27001 accreditation for its information security system 23 October 2023 – Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today...

Optibrium expands operations in North America for AI and computational drug discovery technologies

CAMBRIDGE, UK and CAMBRIDGE, US, 18 October 2022 - Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today announced the opening of its US subsidiary, Optibrium Inc., and the promotion of Dr Tamsin Mansley to President of the new subsidiary to lead its US-based team and business operations. The...

Optibrium and MolPort Collaborate to Improve Speed and Cost-Efficiency of Drug Discovery

CAMBRIDGE, UK and RIGA, LATVIA, 30 November, 2016 - Optibrium™, a developer of software for small molecule design and optimisation, today announced a collaboration with MolPort, the provider of a comprehensive chemicals database, marketplace and order fulfilment platform. The collaboration offers StarDrop™ users fully integrated access to MolPortís drug discovery database of 6.3 million commercially...

Optibrium and Collaborative Drug Discovery Partner on Integration of StarDrop with CDD Vault

CAMBRIDGE, UK and CALIFONIA, USA, 31 October, 2016 - Optibrium™ and Collaborative Drug Discovery (CDD), developers of software products and services for drug discovery and development, today announced a collaboration to integrate the StarDrop™ and CDD Vault platforms. This creates a seamless connection in real time between project data, securely held and managed in CDD...

Optibrium Introduces Database Query Interface for StarDrop

Developer of softwae for small molecule drug discovery announces the launch of database Query Interface for users of StarDrop software

Optibrium and The Edge Collaborate on Integration of StarDrop with BioRails

CAMBRIDGE, UK and GUILDFORD, UK, 20 September, 2016 - Optibrium™ and The Edge Software Consultancy, developers of software products and services for drug discovery and development, today announced a collaboration to provide an integrated solution linking the StarDrop™ and BioRails™ platforms. The combination provides a seamless drug discovery workflow linking the latest research data directly...

Optibrium Signs Agreement for Global License of StarDrop

CAMBRIDGE, UK, 24 May, 2016 - Optibrium, a developer of software for small molecule discovery, today announced that Janssen Research and Development has signed an agreement to license Optibriumís StarDrop software. The agreement will provide a global licence for StarDrop and eight of StarDropís optional plug-in modules. StarDrop is a software suite that helps researchers...
Optibrium Ltd. 7221 Cambridge Research Park, Beach Drive, Cambridge, CB25 9TL, UK

+44 1223 815900